2.06
Ensysce Biosciences Inc Aktie (ENSC) Neueste Nachrichten
Can Ensysce Biosciences Inc. keep up with sector leadersWeekly Trade Review & Weekly High Conviction Ideas - newsyoung.net
Fibonacci Retracement Aligns with Support in Ensysce Biosciences Inc.Weekly Trade Review & AI Enhanced Execution Alerts - 선데이타임즈
Identifying reversal signals in Ensysce Biosciences Inc.Portfolio Performance Summary & Fast Entry High Yield Tips - Newser
Can Ensysce Biosciences Inc. rally from current levelsOptions Play & Reliable Entry Point Trade Alerts - Newser
Can technical indicators confirm Ensysce Biosciences Inc.’s reversalJuly 2025 Highlights & Verified Short-Term Plans - Newser
Ensysce Biosciences 2025 Q2 Earnings 76.4% EPS Improvement Amid Sustained Losses - AInvest
Intraday pattern recognizer results for Ensysce Biosciences Inc.July 2025 Drop Watch & Capital Efficient Trade Techniques - Newser
Real time alert setup for Ensysce Biosciences Inc. performanceJuly 2025 Patterns & Real-Time Volume Trigger Notifications - Newser
Will Ensysce Biosciences Inc. rebound enough to break evenTrade Analysis Report & Fast Gain Stock Trading Tips - Newser
Is Ensysce Biosciences Inc. stock reversal real or fakeCPI Data & Comprehensive Market Scan Insights - Newser
Ensysce Biosciences Advances Opioid Therapy Innovations - TipRanks
Using economic indicators to assess Ensysce Biosciences Inc. potentialTrade Exit Report & Community Consensus Picks - Newser
What technical models suggest about Ensysce Biosciences Inc.’s comebackPortfolio Value Summary & AI Forecasted Stock Moves - Newser
Ensysce Biosciences Narrows Loss in Q2 - The Motley Fool
Ensysce Biosciences Narrows Loss in Q2 - Nasdaq
Ensysce Biosciences: Pioneering Safer Opioids in a High-Risk, High-Reward Biotech Landscape - AInvest
Novel Opioid with Built-in Overdose Protection Enters Final Testing Phase as Ensysce Secures Major Funding - Stock Titan
Published on: 2025-08-13 08:31:33 - Newser
Automated trading signals detected on Ensysce Biosciences Inc.Market Trend Report & Weekly Top Stock Performers List - Newser
Combining price and volume data for Ensysce Biosciences Inc.Gap Up & Free Technical Confirmation Trade Alerts - Newser
Analyzing net buyer seller activity in Ensysce Biosciences Inc.July 2025 Big Picture & Smart Allocation Stock Tips - Newser
Best data tools to analyze Ensysce Biosciences Inc. stockDip Buying & Low Drawdown Trading Techniques - Newser
Backtesting results for Ensysce Biosciences Inc. trading strategiesBreakout Stock Opportunities with Low Drawdown - Newser
What are the future prospects of Ensysce Biosciences Inc.Smart Entry Exit Suggestions - thegnnews.com
Volatility clustering patterns for Ensysce Biosciences Inc.Short-Term Profit Alert With Entry Forecast - Newser
ENSC SEC FilingsEnsysce Biosciences Inc 10-K, 10-Q, 8-K Forms - Stock Titan
Ensysce Biosciences (ENSC) Projected to Post Quarterly Earnings on Wednesday - Defense World
Will breakout in Ensysce Biosciences Inc. lead to full recoveryFree Target Return Focused Trade Insights - Newser
Does Ensysce Biosciences Inc. show high probability of reboundPattern Recognition Based Market Move Prediction - Newser
Is Ensysce Biosciences Inc. stock poised for growthFree Early Entry Tips With Low Risk Zone - Newser
What Fibonacci levels say about Ensysce Biosciences Inc. reboundOversold Reversal Picks with Buy Zone - Newser
Can volume confirm reversal in Ensysce Biosciences Inc.Predictable Return Plan with Entry Guidance - Newser
Ensysce Biosciences Inc. stock outlook for YEARTen-Year Sector Performance and Summary Analysis - Newser
Ensysce Biosciences Inc. stock momentum explainedDaily Pattern Analysis with Return Forecast - Newser
Ensysce Biosciences ENSC Q2 2025 Earnings Preview Downside Risk Amid Competitive Market Challenges - AInvest
Visualizing Ensysce Biosciences Inc. stock with heatmapsWeekly Breakout Forecast with Entry Zones - Newser
What MACD signals say about Ensysce Biosciences Inc.Safe and Scalable Return Strategy Blueprint - Newser
Is Ensysce Biosciences Inc. reversing from oversold territoryFree Oversold Recovery Opportunity Stocks - Newser
Why Ensysce Biosciences Inc. stock attracts strong analyst attentionHigh Return Trade Roadmap with Setup Filters - Newser
Ensysce Biosciences Inc expected to post a loss of $1.18 a shareEarnings Preview - TradingView
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):